{"version":"1.0","type":"link","title":"Mirvetuximab soravtansine-Gynx (MIRV) for treating platinum-resistant recurrent ovarian cancer.","author_name":"Wang PH 외","author_url":"https://prs-insight.online/author/Wang%20PH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/88765","thumbnail_width":1200,"thumbnail_height":630}